Asma Azmani

762 total citations
8 papers, 553 citations indexed

About

Asma Azmani is a scholar working on Neurology, Physiology and Neurology. According to data from OpenAlex, Asma Azmani has authored 8 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Neurology, 5 papers in Physiology and 4 papers in Neurology. Recurrent topics in Asma Azmani's work include Alzheimer's disease research and treatments (5 papers), Amyotrophic Lateral Sclerosis Research (5 papers) and Neurological diseases and metabolism (4 papers). Asma Azmani is often cited by papers focused on Alzheimer's disease research and treatments (5 papers), Amyotrophic Lateral Sclerosis Research (5 papers) and Neurological diseases and metabolism (4 papers). Asma Azmani collaborates with scholars based in Netherlands, United States and Morocco. Asma Azmani's co-authors include John C. van Swieten, Harro Seelaar, Wouter Kamphorst, Iraad F. Bronner, Patrizia Rizzu, Inge de Koning, Annemieke J.M. Rozemüller, Peter Heutink, Burcu Anar and Laura Donker Kaat and has published in prestigious journals such as Brain, Neurology and Journal of Neuropathology & Experimental Neurology.

In The Last Decade

Asma Azmani

8 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Asma Azmani Netherlands 7 413 324 170 141 67 8 553
Lisa Taylor‐Reinwald United States 6 294 0.7× 218 0.7× 101 0.6× 93 0.7× 32 0.5× 6 417
M Stevens Netherlands 6 332 0.8× 415 1.3× 141 0.8× 166 1.2× 115 1.7× 10 562
Denise Levitch United States 6 635 1.5× 226 0.7× 161 0.9× 264 1.9× 23 0.3× 8 766
Myrna A. Dominique United States 5 187 0.5× 143 0.4× 205 1.2× 92 0.7× 58 0.9× 5 386
Tarja Kauppinen Finland 10 289 0.7× 177 0.5× 88 0.5× 106 0.8× 41 0.6× 12 445
Irene Ossola Italy 5 462 1.1× 107 0.3× 111 0.7× 125 0.9× 16 0.2× 7 492
Ira Goodman United States 6 327 0.8× 153 0.5× 97 0.6× 67 0.5× 23 0.3× 11 445
Mustafa Batbayli Denmark 9 129 0.3× 125 0.4× 49 0.3× 235 1.7× 35 0.5× 10 411
Danielle Moreno Canada 14 457 1.1× 111 0.3× 85 0.5× 316 2.2× 22 0.3× 20 675
Linda Rousseau United States 7 173 0.4× 155 0.5× 82 0.5× 105 0.7× 7 0.1× 7 325

Countries citing papers authored by Asma Azmani

Since Specialization
Citations

This map shows the geographic impact of Asma Azmani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asma Azmani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asma Azmani more than expected).

Fields of papers citing papers by Asma Azmani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asma Azmani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asma Azmani. The network helps show where Asma Azmani may publish in the future.

Co-authorship network of co-authors of Asma Azmani

This figure shows the co-authorship network connecting the top 25 collaborators of Asma Azmani. A scholar is included among the top collaborators of Asma Azmani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asma Azmani. Asma Azmani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Azmani, Asma, Sanaâ Lemriss, Mustapha Barakate, et al.. (2022). Screening and Characterization of Streptomyces spp. Isolated from Three Moroccan Ecosystems Producing a Potential Inhibitor of the Drug Efflux Pump AcrAB-TolC. BioTech. 11(3). 22–22. 5 indexed citations
2.
Kaat, Laura Donker, Agnita J.W. Boon, Asma Azmani, et al.. (2009). Familial aggregation of parkinsonism in progressive supranuclear palsy. Neurology. 73(2). 98–105. 42 indexed citations
3.
Seelaar, Harro, Inge de Koning, Aad van der Lugt, et al.. (2009). Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration. Journal of Neurology. 257(5). 747–753. 115 indexed citations
4.
Seelaar, Harro, Wouter Kamphorst, Sonia M. Rosso, et al.. (2008). Distinct genetic forms of frontotemporal dementia. Neurology. 71(16). 1220–1226. 145 indexed citations
5.
Bronner, Iraad F., Patrizia Rizzu, Harro Seelaar, et al.. (2007). Progranulin mutations in Dutch familial frontotemporal lobar degeneration. European Journal of Human Genetics. 15(3). 369–374. 47 indexed citations
6.
Swieten, John C. van, Iraad F. Bronner, Asma Azmani, et al.. (2007). The ΔK280 Mutation in MAP tau Favors Exon 10 Skipping In Vivo. Journal of Neuropathology & Experimental Neurology. 66(1). 17–25. 47 indexed citations
7.
Seelaar, Harro, Helenius J. Schelhaas, Asma Azmani, et al.. (2007). TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutations. Brain. 130(5). 1375–1385. 81 indexed citations
8.
Bronner, Iraad F., Bastiaan C. ter Meulen, Asma Azmani, et al.. (2005). Hereditary Pick's disease with the G272V tau mutation shows predominant three-repeat tau pathology. Brain. 128(11). 2645–2653. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026